Showing results (201-210 of 211) with videos related to
Sort By:
Pageof 22
Scientific Reports|August 23, 2019
Resveratrol Targets Urokinase-Type Plasminogen Activator Receptor Expression to Overcome Cetuximab-Resistance in Oral Squamous Cell CarcinomaKatsuhiro Uzawa, Antonio L Amelio, Atsushi Kasamatsu, et al.Lancet (London, England)|May 15, 2017
Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trialToyoaki Hida, Hiroshi Nokihara, Masashi Kondo, et al.Lung Cancer (Amsterdam, Netherlands)|December 9, 2019
Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancerKazuhiko Nakagawa, Toyoaki Hida, Hiroshi Nokihara, et al.Clinical Lung Cancer|November 19, 2023
A Phase Ⅱ Study of Ubenimex Combined With Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small-Cell Lung Cancer: TORG2241 (UBE-Q)Shinji Nakamichi, Kaoru Kubota, Kotone Matsuyama, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2025
Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834Satoru Miura, Hiroshi Tanaka, Toshihiro Misumi, et al.Cancer Science|October 24, 2021
Predictive value of EGFR mutation in non-small-cell lung cancer patients treated with platinum doublet postoperative chemotherapyToshiaki Takahashi, Kazuko Sakai, Hirotsugu Kenmotsu, et al.Cancer Science|November 13, 2020
Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG-TR)Kazuko Sakai, Masahiro Tsuboi, Hirotsugu Kenmotsu, et al.International Journal of Clinical Oncology|June 15, 2022
Liver biopsy technique in the era of genomic cancer therapies: a single-center retrospective analysisYusuke Ozeki, Naoya Kanogawa, Sadahisa Ogasawara, et al.JGH Open : an Open Access Journal of Gastroenterology and Hepatology|November 24, 2021
Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironmentShohei Mukai, Hiroaki Kanzaki, Sadahisa Ogasawara, et al.JTO Clinical and Research Reports|September 30, 2021
Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With <i>EGFR</i> MutationsKiichiro Ninomiya, Shunsuke Teraoka, Yoshitaka Zenke, et al.Pageof 22